Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Noc Stock Analysis Northrop Grumman Defense Stock Rises 2.16 Percent At 697 Dollar Mark 20260401 1 BOTJ James Bank gains 169 percent as investors react to its newly released Q1 2025 earnings results TGL Treasure Global reports far smaller Q3 2024 loss than analyst forecasts shares dip 162 percent in todays trading session What makes Alarum ALAR a compelling holding for the long term Trades Lower 20260511 US Airline Merger Block Antitrust Enforcement and Sector Market Implications RMI RiverNorth reports negative Q3 2025 EPS and sharp yearoveryear revenue drop as its shares edge higher today Global Refined Product Supply Dislocations and US Retail Fuel Price Dynamics Fidelity Wise Origin Bitcoin Fund FBTC Assessing Investment Viability Amid Crypto ETF Rally and Regulatory Uncertainties Prologis Inc PLD Partners With Clean Power Alliance to Expand Equitable Renewable Energy Access Across Southern California GDEV GDEV Q4 2025 EPS falls short of consensus estimates shares drop 756 on investor disappointment Brook Renew BEP Q1 2026 Results Fall Short EPS 040 Revenue NA AmDrive Wt ADACW Stalls at 038 Breakout or Breakdown 20260518 App Digital APLD Stock Analysis Falls 804 Watching 3718 20260518 Medicus Pharma MDCX Drops 920 Key Support at 029 20260515 Brookfld Biz BBUC Stock Analysis 223 Gain What to Watch 20260520 Japans DBJ Extends Investment Horizon to Boost Domestic Manufacturing Reshoring Asian Markets Rally Nikkei 225 and Kospi Surge as Geopolitical Tensions Ease Titan Machinery TITN Q1 2026 Earnings What Went Wrong and Whats Next CDRE Q1 2026 Earnings EPS Miss Amid Operational Challenges Stock Rises 158 XPeng XPEV Q4 2025 Earnings Strong EPS Beat Fuels Positive Surprise Stock Edges Lower OTEX Q1 2026 Earnings EPS Surpasses Estimates by 75 Stock Declines CETY Q4 2024 Earnings Net Loss of 002 Per Share as Clean Energy Firm Navigates Growth Phase SRPT Q1 2026 Earnings EPS Smashes Estimates by 1847 as Gene Therapy Execution Drives Profit Surprise